Transition to New HIV Treatment Regimens – Procurement and Supply Chain Management Issues. Policy Brief

This policy brief provides advice on a phased approach to transitioning to new HIV treatment regimens, as recommended by the World Health Organization (WHO). The ultimate purpose is to ensure a continuous supply of antiretroviral (ARV) drugs, and ensure rapid and efficient implementation of the new WHO ARV guidelines, with smooth transitioning to new recommended ARV regimens, while reducing the wastage or expiry of products that are no longer recommended.

Approvisionnement, Gestion, Politique

  • Sous-catégories VIH/SIDA
  • Commodities Diagnostiques, Médicaments
  • Date de mise à jour March 2014
  • Version
  • Développé par WHO
  • Quand l'utiliser This policy brief provides advice on a phased approach to transitioning to new HIV treatment regimens, as recommended by the World Health Organization (WHO). The ultimate purpose is to ensure a continuous supply of antiretroviral (ARV) drugs, and ensure rapid and efficient implementation of the new WHO ARV guidelines, with smooth transitioning to new recommended ARV regimens, while reducing the wastage or expiry of products that are no longer recommended.
  • Langues Anglais
  • Niveau d'utilisation Central
  • Forme pdf file
  • Amount of training / TA required n/a
  • Inputs & outputs n/a
  • Coût Free
  • Advantages n/a
  • Contraintes n/a
  • Disponibilité http://apps.who.int/iris/bitstream/10665/104449/1/WHO_HIV_2014.4_eng.pdf?ua=1
  • Remarques n/a
  • Contact hiv-aids@who.int
  • Submission date 2014-03-22 23:55:38